Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nektar Therapeutics's share price for the quarter that ended in Mar. 2026 was MXN1319. Nektar Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 29 Mil. Therefore, Nektar Therapeutics's market cap for the quarter that ended in Mar. 2026 was MXN38,874 Mil.
Nektar Therapeutics's quarterly market cap
increased
from Sep. 2025 (MXN10,672 Mil) to Dec. 2025 (MXN20,990 Mil) and
increased
from Dec. 2025 (MXN20,990 Mil) to Mar. 2026 (MXN38,874 Mil).
Nektar Therapeutics's annual market cap
declined
from Dec. 2023 (MXN9,782 Mil) to Dec. 2024 (MXN3,344 Mil) but then
increased
from Dec. 2024 (MXN3,344 Mil) to Dec. 2025 (MXN20,990 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nektar Therapeutics's Enterprise Value for Today is MXN29,608 Mil.
Nektar Therapeutics (MEX:NKTR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Nektar Therapeutics Market Cap Related Terms
Nektar Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Nektar Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:NKTR vs OCUL, PVLA, GENB: Market Cap Comparison
For the Biotechnology subindustry, Nektar Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nektar Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nektar Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Nektar Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Nektar Therapeutics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nektar Therapeutics (MEX:NKTR) has a Market Cap of MXN38,112 Mil as of Jul. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nektar Therapeutics and its competitors. According to the industry distribution chart, Nektar Therapeutics ranks #156 out of 1427 companies in the Biotechnology industry, placing it in the top 10.9%.
Is Nektar Therapeutics' Market Cap too high?
Nektar Therapeutics' current Market Cap is MXN38,112 Mil. Based on the distribution chart, Nektar Therapeutics ranks #156 out of 1427 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Nektar Therapeutics has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Nektar Therapeutics' Market Cap compare to OCUL and PVLA?
According to the Biotechnology industry distribution chart, Nektar Therapeutics ranks #156 out of 1427 companies for Market Cap. This places Nektar Therapeutics in the top 11% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.04, based on 1,427 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Nektar Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 119.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nektar Therapeutics's current Market Cap is MXN38,112 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nektar Therapeutics stock overvalued right now?
Nektar Therapeutics (MEX:NKTR) has a current Market Cap of MXN38,112 Mil. The stock's GF Value™ is MXN145.62, compared to a current price of MXN1,584.15 — trading 987.9% above its estimated fair value. The current Market Cap is MXN38,112 Mil. Nektar Therapeutics' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Nektar Therapeutics (MEX:NKTR), the current Market Cap is MXN38,112 Mil as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nektar Therapeutics (MEX:NKTR) Overvalued in 2026?
Based on GuruFocus' analysis, Nektar Therapeutics stock appears to be overvalued.
The current stock price of MXN1,584.15 is trading 987.9% above its estimated GF Value™ of MXN145.62.
Key valuation signals for MEX:NKTR:
Market Cap: MXN38,112 Mil
GF Value™: MXN145.62 vs. price of MXN1,584.15 (987.9% above fair value)
No single metric tells the full story. See the MEX:NKTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
47GF Score
Get the complete analysis for MEX:NKTR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:NKTR has been successfully added to your 
